Drugs / Blautix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03721107 | Oct 2018 → May 2020 | irritable bowel syndrome | 4D pharma plc | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Blautix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03721107 ↗ |